290650.KQ
L&C Bio Co., Ltd
KOE · Healthcare · Medical - Specialties · KR
KRW 48,600.00
−10.00%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- KRW 252
- Revenue estimate
- KRW 45.3B
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- KRW 128
- EPS estimate
- KRW 141
- Revenue actual
- KRW 38.3B
- Revenue estimate
- KRW 38.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -9.1%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026